Cat's claw
inhibits
TNF-α
(BioMindmap Proof Quality is Low.)
Cat's claw
inhibits
TNF-α
(BioMindmap Proof Quality is Low.)
1.2
ValidityScore
Valid or Invalid?
-
2001
-
Piscoya J, et al.
-
«Cat's claw had no deleterious effects on blood or liver function or other significant side-effects compared to placebo. Pain associated with activity, medical and patient assessment scores were all significantly reduced, with benefits occurring within the first week of therapy. Knee pain at rest or at night, and knee circumference were not significantly reduced by cat's claw during this brief trial. In vitro tests indicated that U guianensis and U. tomentosa were equivalent at quenching DPPH radicals (EC50, 13.6-21.7 microg/ml) as well as inhibiting TNFalpha production. However, the latter action was registered at much lower concentration (EC50, 10.2-10.9 ng/ml). Cat's claw (10 microg/ml) had no effect on basal PGE2 production, but reduced LPS-induced PGE2 release (P < 0.05), but at higher concentration than that required for TNFalpha inhibition.»
-
added it
3 years ago
on Dec 26, 2018
ranked